JM

John McKearn

GS G.D. Searle: 33 patents #31 of 659Top 5%
PA Pathologica: 9 patents #1 of 10Top 10%
BI Bioenergenix: 5 patents #4 of 7Top 60%
PH Pharmacia: 3 patents #118 of 528Top 25%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
Pfizer: 1 patents #3,022 of 5,153Top 60%
Overall (All Time): #38,035 of 4,157,543Top 1%
61
Patents All Time

Issued Patents All Time

Showing 25 most recent of 61 patents

Patent #TitleCo-InventorsDate
11459307 Heterocyclic compounds for the inhibition of PASK John M. McCall, Donna L. Romero, Michael Clare 2022-10-04
10881626 Controlled release oral pharmaceutical dosage forms comprising MGBG Jeremy Blitzer 2021-01-05
10781185 Heterocyclic compounds for the inhibition of PASK John M. McCall, Donna L. Romero, Michael Clare 2020-09-22
10350178 Methods and compositions for treatment of demyelinating diseases Jeremy Blitzer 2019-07-16
10292950 Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing Jeremy Blitzer 2019-05-21
10085955 Methods and compositions for treatment of demyelinating diseases Jeremy Blitzer 2018-10-02
9868708 Heterocyclic compounds for the inhibition of PASK John M. McCall, Donna L. Romero, Michael Clare 2018-01-16
9675566 Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing Jeremy Blitzer 2017-06-13
9668988 Controlled release oral pharmaceutical dosage forms comprising MGBG Jeremy Blitzer 2017-06-06
9616035 Pharmaceutical for oral delivery comprising MGBG and methods of treating disease Jeremy Blitzer 2017-04-11
9193693 Heterocyclic compounds for the inhibition of PASK John M. McCall, Donna L. Romero, Michael Clare 2015-11-24
8916560 Heterocyclic compounds for the inhibition of PASK John M. McCall, Donna L. Romero, Michael Clare 2014-12-23
8858991 Delayed release oral pharmaceutical dosage forms comprising MGBG Jeremy Blitzer 2014-10-14
8609734 Methods of treating pain with MGBG Jeremy Blitzer 2013-12-17
8258186 Pharmaceutical for oral delivery comprising MGBG Jeremy Blitzer 2012-09-04
7091319 IL-3 variant hematopoiesis fusion protein S. Christopher Bauer, Mark Allen Abrams, Sarah Ruth Braford-Goldberg, Marie Helena Caparon, Alan Michael Easton +4 more 2006-08-15
6916800 Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent Gary B. Gordon, James J. Cunningham, Stephen Gately, Alane T. Koki, Jaime Masferrer 2005-07-12
6858598 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Gary B. Gordon, James J. Cunningham, Stephen Gately, Alane T. Koki, Jaime Masferrer 2005-02-22
6833373 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia Gary B. Gordon, James J. Cunningham, Stephen Gately, Alane T. Koki, Jaime Masferrer 2004-12-21
6730303 Fused G-CSF and IL-3 proteins and uses thereof Yiqing Feng, Nicholas Staten, Charles M. Baum, Neena Summers, Maire Helena Caparon +6 more 2004-05-04
6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia Gary B. Gordon, James J. Cunningham, Stephen Gately, Alane T. Koki, Jaime Masferrer 2004-02-10
6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia Jaime Masferrer, Luka Milas 2003-11-18
6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells S. Christopher Bauer, Mark Allen Abrams, Sarah Ruth Braford-Goldberg, Maire Helena Caparon, Alan Michael Easton +5 more 2002-11-12
6458931 Interleukin-3 (IL-3) multiple mutation polypeptides S. Christopher Bauer, Mark Allen Abrams, Sarah Ruth Bradford-Goldberg, Maire Helena Caparon, Alan Michael Easton +4 more 2002-10-01
6451852 Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives Chi-Dean Liang, John Farah, Richard A. Mueller 2002-09-17